ICT Investment Trends in Pharmaceuticals: Advancements in digital and medical technology nurture ICT investments
Summary "ICT Investment Trends in Pharmaceuticals", report presents the findings from a survey of 130 pharmaceutical companies regarding their Information & Communications Technology (ICT) investment trends. The survey investigates how companies currently allocate their ICT budgets across the core areas of enterprise ICT expenditure: hardware, software, IT services, communications, and consulting.
The report illustrates the core technologies that pharmaceutical companies are investing in, including business intelligence, security products, IoT, and cloud computing. The survey also highlights the approach to purchasing technology adopted by pharmaceutical companies. Through GlobalData’s survey, the report aims to provide a better insight to ICT vendors and service providers when pitching their solutions to pharmaceutical companies. The report focuses on ’ ICT expenditure trends for specific business areas and technologies, identifying the top three IT projects, and understanding the business challenges faced by organizations.
Pharmaceutical sector is one of the biggest contributors to world economy. After sluggish growth in 2016, the appreciating world economy in 2017 has a positive impact on the growth of the pharmaceutical industry. GlobalData’s survey shows that overall ICT expenditure in the pharmaceutical sector is set to increase in 2017 compared to 2016, with a current focus on the core ICT categories of hardware, software, and IT services.
In particular, it provides an in-depth analysis of the following - - How ICT budgets are set to change in 2017 in terms of their overall size - Allocation across the core elements of IT spend, including hardware, software, services, communications, and consulting - Distribution of ICT money in areas such as the networks, applications, service desk, and data centers - Which ICT functions pharmaceutical companies are interested in outsourcing - Pharmaceutical companies’ investment priorities based on their budget allocations across core technology categories such as business intelligence, security products, IoT, and cloud computing - Factors that are influencing pharmaceutical companies’ investments in each technology category - How pharmaceutical companies’ IT budgets are currently allocated across various segments within a technology category - Pharmaceutical companies’ distribution of their ICT budget across various segments within a technology category - Vendor satisfaction ratings for various core and advanced technology categories - Insight into pharmaceutical companies’ preferred buying approaches - Business and IT objectives that pharmaceutical companies are looking to achieve through their IT investment strategies - Factors that are influencing pharmaceutical companies’ decisions to select an ICT provider
Scope - Pharmaceutical companies are continuously looking to improve scalability and reduce cost of ownership. Consequently, they are investing in cloud computing solutions, with a major proportion of the cloud budget allocated towards software as a service (SaaS) and private cloud. - Pharmaceutical companies are opting for business intelligence in order to adapt to the changing trends of the industry while making informed decisions that can add to the growth and profitability of the organization. - IT investments relating to clinical research projects are considered important, with the highest proportion of pharmaceutical companies considering this business area as one of their top IT priorities.
Reasons to buy - Understand how the pharmaceutical enterprises ICT landscape is set to change in 2017 to prioritize your target market - Comprehend how ICT money are being allocated by pharmaceutical enterprises in specific geographies and size bands to improve your market penetration - Make effective business decisions by recognizing the opportunities within each of the core areas of ICT spend (hardware, software, IT services, telecommunications, and consulting) - Realign your sales initiatives by understanding the current strategic objectives of pharmaceutical enterprises - Enhance your market segmentation with the included, detailed breakdown of opportunities within selected technology categories (business intelligence, security products, IoT, and cloud computing) - Prioritize your focus areas by understanding which factors are influencing pharmaceutical enterprises’ decisions when selecting an ICT provider - Understand the changes in customers’ priorities and identify the business objectives that pharmaceutical enterprises are looking to achieve through their ICT investment strategies
Our reports have been used by over 10K customers, including:
238 pages •
By Asia Market Information & Development Company
• Jun 2021
China’s demand for Emerging Pharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer...
175 pages •
By The Business Research Company
• Jul 2021
Major players in the spray drying equipment market are GEA Group; SPX Flow; Shandong Tianli Drying Technology & Equipment; Buchi Labortechnik AG; European SprayDry Technologies; Dedert Corporation; Acmefil Engineering Systems Pvt. Ltd.; Yamato Scientific America Inc.; Swenson Technology Inc.; Tetra Pak International S.A.; Saka Engineering...
Iduronate 2 Sulfatase - Drugs In Development, 2021 Summary According to the recently published report ’Iduronate 2 Sulfatase - Drugs In Development, 2021’; Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 22.214.171.124) pipeline Target constitutes close to 10 molecules....
Anesthesia is one of the most essential components for any surgical procedure. It induces temporary unconsciousness and loss of protective reflexes. According to the Centers for Disease Control and Prevention (CDC), more than 51 million inpatient surgeries and 53 million outpatient surgeries were performed in the United States in 2017, with...
528 pages •
By Global Industry Analysts
• May 2021
Global Pharmaceutical Contract Manufacturing Market to Reach $130.2 Billion by 2026
Pharmaceutical contract manufacturing refers to outsourcing of the manufacturing function of pharmaceutical products. Outsourcing manufacturing processes allows hiring pharmaceutical companies...
The Global Antibody Partnering Terms and Agreements 2014 to 2021 report provides comprehensive understanding and unprecedented access to the Antibody partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies...
978 pages •
By Global Industry Analysts
• May 2021
Global CNS Therapeutics Market to Reach US$144.2 Billion by the Year 2027
Amid the COVID-19 crisis, the global market for CNS Therapeutics estimated at US$103.4 Billion in the year 2020, is projected to reach a revised size of US$144.2 Billion by 2027, growing at a CAGR of 4.9% over...
Mergers and Acquisitions (M&A) in the Pharmaceutical Contract Manufacturing Industry - Implications and Outlook - 2021 Edition
This report is the third edition of our analysis of mergers and acquisitions in the pharmaceutical contract manufacturing industry. PharmSource is the most definitive,...
The global empty capsules market is projected to reach USD 3.7 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 7.2% during the forecast period. The overall growth of the empty capsules market is largely driven by the growing adoption of capsule formulations among the growing geriatric population, the growth of the pharmaceutical...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.